Skip to search formSkip to main contentSkip to account menu

tolamolol

Known as: 4-(2-(2-hydroxy-3-o-tolyloxypropylamino)ethoxy)benzamide, totamidol 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2003
Highly Cited
2003
The chiral resolution of some clinically used drugs namely metoprolol, teratolol, tolamolol, nebivolol (beta-adrenergic blockers… 
Highly Cited
1979
Highly Cited
1979
We compared the immediate effects of five beta-adrenoreceptor-blocking agents in 16 patients with stable angina pectoris. Acute… 
1979
1979
2 Oxygen consumption, heart rate, cardiac (Cardiogreen) and intraarterial brachial BP were recorded supine and sitting position… 
1977
1977
1 Twelve men with untreated essential hypertension in WHO stage I were studied on an outpatient basis to evaluate the… 
Highly Cited
1976
Highly Cited
1976
pA2 values against isoproterenol were determined for a number of cardioselective and noncardioselective beta adrenergic receptor… 
1976
1976
Tolamolol (UK-6558-01) is a relatively cardioselective beta receptor antagonist which is effective clinically in the treatment of… 
1975
1975
Forty-two patients with angina pectoris have completed a randomized, double-blind trial comparing tolamolol 100 mg and 200 mg… 
1975
1975
Pharmacokinetic and physiological variables were measured in six healthy subjects after intravenous and oral administration of… 
1973
1973
Orally administered tolamolol, a new cardioselective beta-adrenergic blocking drug, was evaluated in 30 patients with…